SEC Form 4 · accession 0001267490-26-000008
Serina Therapeutics, Inc. · SER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen J Wilson
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 7:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001708599
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 30,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.98 | Jun 17, 2026 | A | 15,250 | A | — | Jun 17, 2036 | Common Stock | 15,250 | 15,250 | D |
Explanation of responses
- F1This row is being reported to update the previously reported number of shares beneficially owned by the Reporting Person and does not reflect an unreported transaction.
- F2The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.